Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Liberatore, Gabriel T., Jackson-Lewis, Vernice, Vukosavic, Slobodanka, Mandir, Allen S., Vila, Miquel, McAuliffe, W. Geoffrey, Dawson, Valina L., Dawson, Ted M. +1 more·1999·Nature Medicine

Cited by (1,000)

Items 401–500 of 1,000

  1. Role of Microglia Adenosine A2AReceptors in Retinal and Brain Neurodegenerative Diseases
    Ana Raquel Santiago, Filipa I. Baptista, Paulo F. Santos, Gonçalo Cristóvão, António Francisco Ambrósio, Rodrigo Antunes Cunha, Catarina A. Gomes · 2014 · Mediators of Inflammation
  2. Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson’s disease
    Ying Chi, Yi Fan, Lei He, Wei Yong Liu, Xiaoyun Wen, Sha Zhou, Xuefeng Wang, Cui Zhang, Hui Kong, Laura Sonoda et al. · 2011 · Aging Cell
  3. Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease
    Ross B. Mounsey, Sarah Mustafa, Lianne Robinson, Ruth A. Ross, Gernot Riedel, Roger G. Pertwee, Peter Teismann · 2015 · Experimental Neurology
  4. Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats
    Marcelo de Meira Santos Lima, Angela B. Reksidler, Sílvio Marques Zanata, Hidevaldo B. Machado, Sérgio Tufik, Maria A.B.F. Vital · 2006 · Brain Research
  5. l ‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
    Anna Rosa Carta, Giovanna Mulas, Mariza Bortolanza, Terence Teixeira Duarte, Elisabetta Pillai, Gilberto Fisone, Rita Raisman‐Vozari, Elaine Aparecida Del Bel · 2016 · European Journal of Neuroscience
  6. Critical role of the Mac1/NOX2 pathway in mediating reactive microgliosis-generated chronic neuroinflammation and progressive neurodegeneration
    Chen, Shih-Heng, Oyarzabal, Esteban A, Hong, Jau-Shyong · 2016 · Current Opinion in Pharmacology
  7. The Positive Role and Mechanism of Herbal Medicine in Parkinson’s Disease
    Rong L. Yin, Jie Xue, Yanfeng Tan, Chuantao Fang, Chunchun Hu, Qian Yang, Xinyu Mei, Dashi Qi · 2021 · Oxidative Medicine and Cellular Longevity
  8. Molecular mechanism of manganese exposure-induced dopaminergic toxicity
    Krishnan Prabhakaran, Debabrata Ghosh, Gail D. Chapman, Palur G. Gunasekar · 2008 · Brain Research Bulletin
  9. Neuroprotection by Transgenic Expression of Glucose-6-Phosphate Dehydrogenase in Dopaminergic Nigrostriatal Neurons of Mice
    Rebeca Mejı́as, Javier Villadiego, C. Oscar Pintado, Pablo J. Vime, Lin Gao, Juan José Toledo‐Aral, Miriam Echevarrı́a, José López‐Barneo · 2006 · Journal of Neuroscience
  10. Transient receptor potential vanilloid subtype 1 contributes to mesencephalic dopaminergic neuronal survival by inhibiting microglia-originated oxidative stress
    Eun Su Park, Sang Ryong Kim, Byung Kwan Jin · 2012 · Brain Research Bulletin
  11. Hypersensitivity of aquaporin 4-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine and astrocytic modulation
    Yi Fan, Hui Kong, Xueru Shi, Xiu‐Lan Sun, Jianhua Ding, Jie Wu, Gang Hu · 2007 · Neurobiology of Aging
  12. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms
    Céline Perier, Andreas Bender, Elena García‐Arumí, M Melia, Jordi Bové, Christoph Laub, Thomas Klopstock, Matthias Elstner, Ross B. Mounsey, Peter Teismann et al. · 2013 · Brain
  13. Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
    Teismann, Peter, Sathe, Kinnari, Bierhaus, Angelika, Leng, Lin, Martin, Heather L., Bucala, Richard, Weigle, Bernd, Nawroth, Peter P., Schulz, Jörg B. · 2012 · Neurobiology of Aging
  14. Corylin inhibits LPS-induced inflammatory response and attenuates the activation of NLRP3 inflammasome in microglia
    Ming‐Yii Huang, Chia-En Tu, Shu‐Chi Wang, Yung‐Li Hung, Chia‐Cheng Su, Shih‐Hua Fang, Chi‐Shuo Chen, Po‐Len Liu, Wei‐Chung Cheng, Yuwei Huang et al. · 2018 · BMC Complementary and Alternative Medicine
  15. Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease
    Nataša Z. Kuštrimović, Franca Marino, Marco Cosentino · 2018 · Current Medicinal Chemistry
  16. Chemokines in the MPTP model of Parkinson’s disease: Absence of CCL2 and its receptor CCR2 does not protect against striatal neurodegeneration
    Yogeshwar V. Kalkonde, WILLIAM W. MORGAN, José A. Sigala, Shivani Kaushal Maffi, Carlo Condello, William A. Kuziel, Seema S. Ahuja, Sunil K. Ahuja · 2006 · Brain Research
  17. Small Molecule c-jun-N-Terminal Kinase Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson’s Disease
    Jeremy W. Chambers, Alok S. Pachori, Shannon Howard, Michelle L. Ganno, Donald Hansen, Ted Kamenecka, Xinyi Song, Derek R. Duckett, Wei‐Min Chen, Yuan Yuan Ling et al. · 2011 · ACS Chemical Neuroscience
  18. Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease
    Jianhua Zhang, Matilda Lillian Culp, Jason Craver, Victor M. Darley-Usmar · 2018 · Journal of Neurochemistry
  19. Intranasal PRGF-Endoret enhances neuronal survival and attenuates NF-κB-dependent inflammation process in a mouse model of Parkinson's disease
    Eduardo Anitua, Consuelo Pascual, Rocío Pérez‐González, Gorka Orive, Eva Carro · 2015 · Journal of Controlled Release
  20. TGF‐β1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS‐2
    Mary E. Hamby, James A. Hewett, Sandra J. Hewett · 2006 · Glia
  21. The Essential Role of Drp1 and Its Regulation by S-Nitrosylation of Parkin in Dopaminergic Neurodegeneration: Implications for Parkinson's Disease
    Zhenzhen Zhang, Lei Liu, Xiaoxiao Jiang, Shaodong Zhai, Da Xing · 2016 · Antioxidants and Redox Signaling
  22. Luteolin Inhibits Microglial Inflammation and Improves Neuron Survival Against Inflammation
    Li-Hong Zhu, Wei Bi, Renbin Qi, Huadong Wang, Daxiang Lu · 2011 · International Journal of Neuroscience
  23. In vivo evidence for microglial activation in neurodegenerative dementia
    Annachiara Cagnin, Michael Kassiou, Steven R. Meikle, Richard B. Banati · 2006 · Acta Neurologica Scandinavica
  24. Quantitative1H Magnetic Resonance Spectroscopic Imaging Determines Therapeutic Immunization Efficacy in an Animal Model of Parkinson's Disease
    Michael D. Boska, Travis B. Lewis, Christopher J. Destache, Eric J. Benner, Jay A. Nelson, Mariano Uberti, Rodney Lee Mosley, Howard Eliot Gendelman · 2005 · Journal of Neuroscience
  25. Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide
    Maria C. Morale, Pier Andrea Serra, Maria Rosaria Delogu, Rossana Migheli, Gaia Rocchitta, Cataldo Tirolo, Salvo Caniglia, Nunzio Testa, Francesca L’Episcopo, Florinda Gennuso et al. · 2003 · The FASEB Journal
  26. Downregulation of miR‐7116‐5p in microglia by MPP + sensitizes TNF‐α production to induce dopaminergic neuron damage
    Qian He, Qing Wang, Chao Yuan, Yizheng Wang · 2017 · Glia
  27. Inhibitors of NLRP3 Inflammasome in Ischemic Heart Disease: Focus on Functional and Redox Aspects
    Pasquale Pagliaro, Claudia Renata Rezende Penna · 2023 · Antioxidants
  28. A fast and selective two-photon phosphorescent probe for the imaging of nitric oxide in mitochondria
    Xiang Chen, Lingli Sun, Yu Chen, Xiaolin Cheng, Weijun Wu, Liang‐Nian Ji, Hui Chao · 2015 · Biomaterials
  29. Analysis of monocyte infiltration in MPTP mice reveals that microglial CX3CR1 protects against neurotoxic over-induction of monocyte-attracting CCL2 by astrocytes
    Vincent R. Parillaud, G. Lornet, Y. Monnet, A. Privat, Andrei T. Haddad, V. Brochard, A. Bekaert, Camille Baudesson de Chanville, E. Hirsch, C. Combadière et al. · 2017 · Journal of Neuroinflammation
  30. Constructing a novel composite of molecularly imprinted polymer-coated AuNPs electrochemical sensor for the determination of 3-nitrotyrosine
    Shiqiao Wang, Guohan Sun, Zuanguang Chen, Yawen Liang, Qing Zhou, Yufang Pan, Haiyun Zhai · 2017 · Electrochimica Acta
  31. Inflammation and dopaminergic neuronal loss in Parkinson's disease: a complex matter
    Andreas Hartmann, Stéphane Hunot, Étienne C. Hirsch · 2003 · Experimental Neurology
  32. Inflammatory Mediators Leading to Protein Misfolding and Uncompetitive/Fast Off‐Rate Drug Therapy for Neurodegenerative Disorders
    Stuart A. Lipton, Zezong Gu, Tomohiro Nakamura · 2007 · International review of neurobiology
  33. Tanshinone IIA prevents the loss of nigrostriatal dopaminergic neurons by inhibiting NADPH oxidase and iNOS in the MPTP model of Parkinson's disease
    Bo Xu Ren, Yuxin Zhang, Hongxia Zhou, Fa-wei Sun, Zuo-feng Zhang, Zi-feng Wei, Cheng-yun Zhang, Daowen Si · 2014 · Journal of the Neurological Sciences
  34. Manganese potentiates lipopolysaccharide-induced expression of NOS2 in C6 glioma cells through mitochondrial-dependent activation of nuclear factor kappaB
    Rola Barhoumi, Jennifer B. Faske, Xuhong Liu, Ronald B. Tjalkens · 2004 · Molecular Brain Research
  35. Triptolide, a Chinese herbal extract, protects dopaminergic neurons from inflammation-mediated damage through inhibition of microglial activation
    Fengqiao Li, Xiu-Zhi Lu, Xibin Liang, Hui-Fang Zhou, Bing Xue, Xianyu Liu, Dong-Bin Niu, Ji‐Sheng Han, Xiaomin Wang · 2004 · Journal of Neuroimmunology
  36. Folic Acid Is Able to Polarize the Inflammatory Response in LPS Activated Microglia by Regulating Multiple Signaling Pathways
    Antonia Cianciulli, Rosaria Salvatore, Chiara Porro, Teresa Trotta, Maria Antonietta Panaro · 2016 · Mediators of Inflammation
  37. Estrogen blocks inducible nitric oxide synthase accumulation in LPS-activated microglia cells
    Elisabetta Vegeto, Giuseppe Pollio, Paolo Ciana, Adriana C. Maggi · 2000 · Experimental Gerontology
  38. Organophosphate Pesticide Exposures, Nitric Oxide Synthase Gene Variants, and Gene–Pesticide Interactions in a Case–Control Study of Parkinson’s Disease, California (USA)
    Kimberly C. Paul, Janet S. Sinsheimer, Shannon L. Rhodes, Myles Cockburn, Jeff M. Bronstein, Beate R. Ritz · 2015 · Environmental Health Perspectives
  39. Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
    Elena González‐Rey, Nieves Varela, Alejo Chorny, Mario Delgado · 2007 · Current Pharmaceutical Design
  40. Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice
    Hernan Cardenas, Laurel M. Bolin · 2003 · Brain Research
  41. Bone Marrow-Derived Mesenchymal Stem Cell Therapy as a Candidate Disease-Modifying Strategy in Parkinson's Disease and Multiple System Atrophy
    Phil Hyu Lee, Hyun Jung Park · 2009 · Journal of Clinical Neurology
  42. Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy
    Bin Liu, Arthur H. Neufeld · 2003 · Neurobiology of Disease
  43. Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease
    Santiago Canals, Marı́a José Casarejos, Sonsoles de Bernardo, Eulalia Rodríguez‐Martín, M. A. Mena · 2001 · Journal of Neurochemistry
  44. Vulnerability of mesostriatal dopaminergic neurons in Parkinson’s disease
    González-Hernández, Tomás · 2010 · Frontiers in Neuroanatomy
  45. Ellagic Acid Prevents Dopamine Neuron Degeneration from Oxidative Stress and Neuroinflammation in MPTP Model of Parkinson’s Disease
    Mustafa Taleb Ardah, Greeshma Bharathan, Tohru Kitada, M. Emdadul Haque · 2020 · Biomolecules
  46. Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys.
    S. D. Hurley, M. O'Banion, David D. Song, F. S. Arana, J. Olschowka, S. Haber · 2003 · Experimental Neurology
  47. Manganese potentiates nuclear factor‐κB‐dependent expression of nitric oxide synthase 2 in astrocytes by activating soluble guanylate cyclase and extracellular responsive kinase signaling pathways
    Julie A. Moreno, Kelly A. Sullivan, David L. Carbone, William H. Hanneman, Ronald B. Tjalkens · 2008 · Journal of Neuroscience Research
  48. Attenuation of MPTP neurotoxicity by rolipram, a specific inhibitor of phosphodiesterase IV
    Lichuan Yang, Noel Ylagan Calingasan, Beverly J. Lorenzo, M. Flint Beal · 2007 · Experimental Neurology
  49. Oxidation of mitochondrial deoxynucleotide pools by exposure to sodium nitroprusside induces cell death
    Junji Ichikawa, Daisuke Tsuchimoto, Sugako Oka, Mizuki Ohno, Masato Furuichi, Kunihiko Sakumi, Yusaku Nakabeppu · 2007 · DNA repair
  50. l -DOPA-induced dyskinesia in Parkinson's disease: Are neuroinflammation and astrocytes key elements?
    Elaine Aparecida Del Bel, Mariza Bortolanza, Maurício dos Santos Pereira, Keila Bariotto‐dos‐Santos, Rita Raisman‐Vozari · 2016 · Synapse
  51. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor
    Concepción García, María Gómez‐Cañas, Sonia Burgaz, Belén Palomares, Yolanda Gómez‐Gálvez, Cristina Palomo‐Garo, Sara Campo, Joel Ferrer-Hernández, Carolina Pavicic, Carmen M. Navarrete et al. · 2018 · Journal of Neuroinflammation
  52. Apelin-36 mediates neuroprotective effects by regulating oxidative stress, autophagy and apoptosis in MPTP-induced Parkinson’s disease model mice
    Zhu, Junge, Gao, Wenming, Shan, Xuehua, Wang, Chunmei, Wang, Huiqing, Shao, Ziqi, Dou, Shanshan, Jiang, Yunlu, Wang, Chuangong, Cheng, Baohua · 2020 · Brain Research
  53. Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative Diseases
    Tomohiro Nakamura, Stuart A. Lipton · 2019 · Antioxidants and Redox Signaling
  54. The Role of Astroglia on the Survival of Dopamine Neurons
    María A. Mena, Sonsoles de Bernardo, Marı́a José Casarejos, Santiago Canals, Eulalia Rodríguez‐Martín · 2002 · Molecular Neurobiology
  55. Co-induction of argininosuccinate synthetase, cationic amino acid transporter-2, and nitric oxide synthase in activated murine microglial cells
    Kohichi Kawahara, Tomomi Gotoh, Seiichi Oyadomari, Makoto Kajizono, Akihiko Kuniyasu, Keiko Ohsawa, Yoshinori Imai, Shinichi Kohsaka, Hitoshi Nakayama, Masataka Mori · 2001 · Molecular Brain Research
  56. Gene disruption of caspase-3 prevents MPTP-induced Parkinson’s disease in mice
    Marina Yamada, Kotaro Kida, Willington Amutuhaire, Fumito Ichinose, Masao Kaneki · 2010 · Biochemical and Biophysical Research Communications
  57. The involvement of nitric oxide in maneb- and paraquat-induced oxidative stress in rat polymorphonuclear leukocytes
    Israr Ahmad, Ashutosh Kumar, Smriti Shukla, Haushila Prasad Pandey, Chetna Singh · 2008 · Free Radical Research
  58. Pesticides, Microglial NOX2, and Parkinson's Disease
    Thomas Taetzsch, Michelle L. Block · 2013 · Journal of Biochemical and Molecular Toxicology
  59. Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration
    Christine V. Fontanilla, Zhizhong Ma, X. Wei, Jens Klotsche, Liming Zhao, Paul Wisniowski, Richard C. Dodel, Martin Rhys Farlow, Wolfgang Hermann Oertel, Yansheng Du · 2011 · Neuroscience
  60. Minocycline and Other Tetracycline Derivatives: A Neuroprotective Strategy in Parkinson’s Disease and Huntington’s Disease
    Thomas, Madhavi, Le, Wei Dong, Jankovic, Joseph · 2003 · Clinical Neuropharmacology
  61. Mapping neuroinflammation in frontotemporal dementia with molecular PET imaging
    Zhang, Jing · 2015 · Journal of Neuroinflammation
  62. Risk Factors for Phenoconversion in Rapid Eye Movement Sleep Behavior Disorder
    Hui Zhang, Álex Iranzo, Birgit Högl, Isabelle Arnulf, Luigi Ferini‐Strambi, Raffaele Manni, Tomoyuki Miyamoto, Wolfgang Hermann Oertel, Yves A Dauvilliers, Yo‐El S. Ju et al. · 2022 · Annals of Neurology
  63. Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease
    Adalberto Alves de Castro, Bárbara Paula Wiemes, Filipe Carvalho MATHEUS, Fernanda da Rocha Lapa, Giordano Gübert Viola, Adair R.S. Santos, Carla I. Tasca, Rui Daniel Prediger · 2013 · Brain Research
  64. Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin
    Sam V. Kaplan, Ryan Limbocker, Rachel C. Gehringer, Jenny L. Divis, Gregory L. Osterhaus, Maxwell D. Newby, Michael J. Sofis, David P. Jarmolowicz, Brooke D. Newman, Tiffany A. Mathews et al. · 2016 · ACS Chemical Neuroscience
  65. Trisialoganglioside GT1b induces in vivo degeneration of nigral dopaminergic neurons: Role of microglia
    Jae Kyu Ryu, Won H. Shin, Jean Kim, Eun H. Joe, Yong B. Lee, Kyung G. Cho, Young J. Oh, Seung Up Kim, Byung Kwan Jin · 2002 · Glia
  66. Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson’s disease
    Yu Watanabe, Hiroyuki Kato, Tsutomu Araki · 2007 · Metabolic Brain Disease
  67. Neuroprotective Actions of Coenzyme Q10 in Parkinson's Disease
    S Sharma, M Kheradpezhou, S Shavali, Hesham El Refaey, Josh Eken, C Hagen, Manuchair Ebadi · 2004 · Methods in enzymology on CD-ROM/Methods in enzymology
  68. Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinsons Disease
    Randy L. Hunter, Guoying Bing · 2007 · Current Neuropharmacology
  69. Molecular mechanisms of nitrosative stress-mediated protein misfolding in neurodegenerative diseases
    Tomohiro Nakamura, Stuart A. Lipton · 2007 · Cellular and Molecular Life Sciences
  70. Defining the contribution of neuroinflammation to Parkinson’s disease in humanized immune system mice
    Gunjan Dhawan Manocha, Angela Marie Floden, Kendra L. Puig, Kumi Nagamoto‐Combs, Clemens R. Scherzer, Colin Kelly Combs · 2017 · Molecular Neurodegeneration
  71. Antisense Oligodeoxynucleotide to Inducible Nitric Oxide Synthase Protects against Transient Focal Cerebral Ischemia—Induced Brain Injury
    Sophie Parmentier‐Batteur, Georg Andrees Böhme, Dominique Lerouet, Li Zhou-Ding, Virginie Beray‐Berthat, Isabelle Margaill, Michel Plotkine · 2001 · Journal of Cerebral Blood Flow & Metabolism
  72. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
    Francesca L’Episcopo, Cataldo Tirolo, Salvatore Caniglia, Nunzio Testa, Pier Andrea Serra, Francesco Impagnatiello, Maria C. Morale, Bianca Marchetti · 2010 · Journal of Neuroinflammation
  73. Neuronal NOS and cyclooxygenase-2 contribute to DNA damage in a mouse model of Parkinson disease
    Tuan Hoang, Dong‐Kug Choi, Makiko Nagai, Du Chu Wu, Tetsuya Nagata, Delphine Prou, Glenn L. Wilson, Miquel Vila, Vernice R. Jackson-Lewis, Valina Lynn Dawson et al. · 2009 · Free Radical Biology and Medicine
  74. Castration Induces Parkinson Disease Pathologies in Young Male Mice via Inducible Nitric-oxide Synthase
    Saurabh Khasnavis, Anamitra Ghosh, Avik Roy, Kalipada Pahan · 2013 · Journal of Biological Chemistry
  75. A Microchip‐Based System for Immobilizing PC 12 Cells and Amperometrically Detecting Catecholamines Released After Stimulation with Calcium
    Michelle W. Li, Dana M. Spence, R. Scott Martin · 2005 · Electroanalysis
  76. Ameliorating effects of curcumin on 6-OHDA-induced dopaminergic denervation, glial response, and SOD1 reduction in the striatum of hemiparkinsonian mice.
    Wanida Tripanichkul, Jaroensuppaperch Eo · 2013 · PubMed
  77. Nitric oxide mediates glial-induced neurodegeneration in Alexander disease
    Liqun Wang, Tracy L. Hagemann, Hermann Kalwa, Thomas M. Michel, Albee Messing, Mel Β. Feany · 2015 · Nature Communications
  78. Impaired CBS-H2S signaling axis contributes to MPTP-induced neurodegeneration in a mouse model of Parkinson’s disease
    Yuqing Yuan, Yali Wang, Baoshi Yuan, Xin Yuan, Xiao‐Ou Hou, Jin‐Song Bian, Chun‐Feng Liu, Li‐Fang Hu · 2017 · Brain Behavior and Immunity
  79. Temporal effects of paraquat/maneb on microglial activation and dopamine neuronal loss in older rats
    Martine Saint‐Pierre, Marie‐Ève Tremblay, Attila Gabor SIK, Robert E. Gross, Francesca Cicchetti · 2006 · Journal of Neurochemistry
  80. Age- and sex-differences in the nitric oxide synthase expression and dopamine concentration in the murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
    Ilona Joniec‐Maciejak, Agnieszka Ciesielska, Iwona Kurkowska‐Jastrzębska, Adam M. Przybyłkowski, Anna Członkowska, Andrzej Członkowski · 2009 · Brain Research
  81. Glucocorticoid receptor–nitric oxide crosstalk and vulnerability to experimental parkinsonism: pivotal role for glia–neuron interactions
    Bianca Marchetti, Pier Andrea Serra, Cataldo Tirolo, Francesca L’Episcopo, Salvatore Caniglia, Florinda Gennuso, Nunzio Testa, EGIDIO MIELE, Speranza Desole, Nicholas Barden et al. · 2005 · Brain Research Reviews
  82. Developmental Exposure to Manganese Increases Adult Susceptibility to Inflammatory Activation of Glia and Neuronal Protein Nitration
    Julie A. Moreno, Karin M. Streifel, Kelly A. Sullivan, Marie E. Legare, Ronald B. Tjalkens · 2009 · Toxicological Sciences
  83. Apoptosis‐inducing factor deficiency sensitizes dopaminergic neurons to parkinsonian neurotoxins
    Céline Perier, Jordi Bové, Benjamin Dehay, Vernice R. Jackson-Lewis, Peter S. Rabinovitch, Serge Przedborski, Miquel Vila · 2010 · Annals of Neurology
  84. Neuroinflammation and Parkinson's disease.
    S. Przedborski · 2007 · Handbook of Clinical Neurology
  85. Intranigral infusion of interleukin‐1β activates astrocytes and protects from subsequent 6‐hydroxydopamine neurotoxicity
    Josep Saura, Mireia Parés, Jordi Bové, Susana Pezzi, Jordi Alberch, Concepció Marı́n, EDUARDO S. TOLOSA, Marı́a José Martı́ · 2003 · Journal of Neurochemistry
  86. Nitric oxide, glial cells and neuronal degeneration in parkinsonism
    Étienne C. Hirsch, Stéphane Hunot · 2000 · Trends in Pharmacological Sciences
  87. Inhibition of NLRP3 inflammasome by glibenclamide attenuated dopaminergic neurodegeneration and motor deficits in paraquat and maneb-induced mouse Parkinson’s disease model
    Xiaofei Qiu, Qinghui Wang, Liyan Hou, Cuili Zhang, Qingshan Wang, Xiulan Zhao · 2021 · Toxicology Letters
  88. Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases
    Qingshan Wang, Chun‐Hsien Chu, Esteban A. Oyarzabal, Lulu Jiang, Shih‐Heng Chen, Belinda C. Wilson, Qian Li, Jau‐Shyong Hong · 2014 · Glia
  89. Mitochondrial Permeability Transition Pore Component Cyclophilin D Distinguishes Nigrostriatal Dopaminergic Death Paradigms in the MPTP Mouse Model of Parkinson's Disease
    Bobby Thomas, Rebecca Banerjee, Natalia N. Starkova, Steven F. Zhang, Noel Ylagan Calingasan, Lichuan Yang, Elizabeth J. Wille, Beverly J. Lorenzo, Daniel J. Ho, M. Flint Beal et al. · 2011 · Antioxidants and Redox Signaling
  90. Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson’s model: a promising candidate for the treatment of Parkinson’s disease
    Wu-Fu Chen, Chiranjib Chakraborty, Chun‐Sung Sung, Chien‐Wei Feng, Yen‐Hsuan Jean, Yen‐You Lin, Han-Chun Hung, Tzu-Yi Huang, Shiying Huang, Thung-Ming Su et al. · 2011 · Naunyn-Schmiedeberg s Archives of Pharmacology
  91. Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease
    Hironori Yokoyama, Hiroto Uchida, Hayato Kuroiwa, Jiro Kasahara, Tsutomu Araki · 2010 · Neurological Sciences
  92. Growth/differentiation factor-15 deficiency compromises dopaminergic neuron survival and microglial response in the 6-hydroxydopamine mouse model of Parkinson's disease
    Venissa Machado, Stefan Jean-Pierre Haas, Oliver von Bohlen und Halbach, Andreas Wree, Kerstin G. KRIEGLSTEIN, Klaus Unsicker, Björn Spittau · 2015 · Neurobiology of Disease
  93. Ginsenoside Rb1 confers neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson's disease
    Yun‐Long Zhang, Yan Liu, Xin-Pan Kang, Chun-Yan Dou, Rengong Zhuo, Shuqiong Huang, Li Peng, Lei Wen · 2017 · Neuropharmacology
  94. Phenothiazine normalizes the NADH/NAD+ ratio, maintains mitochondrial integrity and protects the nigrostriatal dopamine system in a chronic rotenone model of Parkinson's disease
    Vı́ctor Tapias, Jennifer L. McCoy, J. Timothy Greenamyre · 2019 · Redox Biology
  95. Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease
    Gregory R. J. Thatcher, Brian M. Bennett, James N. Reynolds · 2005 · Current Alzheimer Research
  96. An Investigation of the Neuroprotective Effects of Tetracycline Derivatives in Experimental Models of Retinal Cell Death
    Baptiste, Darryl C, Hartwick, Andrew T. E, Jollimore, Christine A. B, Baldridge, William H, Seigel, Gail M, Kelly, Melanie E. M · 2004 · Molecular Pharmacology
  97. Dysregulation of tyrosinase activity: a potential link between skin disorders and neurodegeneration
    Wanli Jin, Samantha J. Stehbens, Ross Thomas Barnard, Mark A. T. Blaskovich, Zyta Maria Ziora · 2023 · Journal of Pharmacy and Pharmacology
  98. Neuroprotective strategies in parkinson’s disease: protection against progressive nigral damage induced by free radicals
    Chuang C. Chiueh, Tsugunobu Andoh, Andrew Ryan Lai, Edgar Lai, Gopal A. Krishna · 2000 · Neurotoxicity Research
  99. Bone marrow-derived mesenchymal stem cells modulate BV2 microglia responses to lipopolysaccharide
    Yin Yin Ooi, Rajesh Ramasamy, Zul'atfi Rahmat, Hemavathy Subramaiam, Shi Wei Tan, Maha Abdullah, Daud Ahmad Israf, Sharmili Vidyadaran · 2010 · International Immunopharmacology
  100. Impact of endogenous nitric oxide on microglial cell energy metabolism and labile iron pool
    Benoı̂t Chénais, Hamid Morjani, Jean‐Claude Drapier · 2002 · Journal of Neurochemistry